NCT01593995View on ClinicalTrials.gov

EGF Ointment for Erlotinib Skin Lesion

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

October 31, 2014

Conditions
Non-small Cell Lung CancerPancreatic Cancer
Interventions
DRUG

Epidermal growth factor (EGF) ointment

"EGF Ointment evenly apply to skin lesion every 12 hr/ day. If the skin lesion has been no improvement even though EGF ointment applied for 8 weeks, stopped study and assess it as no effect"

Trial Locations (1)

602-715

Dong-A University Hospital, Busan

All Listed Sponsors
lead

Dong-A University Hospital

OTHER

NCT01593995 - EGF Ointment for Erlotinib Skin Lesion | Biotech Hunter | Biotech Hunter